Filing Details

Accession Number:
0000950170-24-071333
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-10 16:29:56
Reporting Period:
2024-06-06
Accepted Time:
2024-06-10 16:29:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1697532 Applied Therapeutics Inc. APLT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1775490 Shoshana Shendelman C/O Applied Therapeutics, Inc.
545 Fifth Avenue, Suite 1400
New York NY 10017
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-06-06 61,795 $4.32 3,756,019 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,750,000 Indirect See footnote
Common Stock 1,492,094 Indirect See footnote
Common Stock 709,720 Indirect See footnote
Common Stock 290,280 Indirect See footnote
Common Stock 88,397 Indirect See footnote
Footnotes
  1. The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
  2. Through a grantor retained annuity trust.
  3. Through a family trust controlled by the reporting person's spouse.
  4. Through the reporting person's spouse.
  5. Through a family trust controlled by the reporting person.
  6. Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.